awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33835866-CDA57797-E670-4CAA-8913-E0135498E6AA
Q33835866-CDA57797-E670-4CAA-8913-E0135498E6AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33835866-CDA57797-E670-4CAA-8913-E0135498E6AA
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II
P2860
Q33835866-CDA57797-E670-4CAA-8913-E0135498E6AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33835866-CDA57797-E670-4CAA-8913-E0135498E6AA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68faa3939132460a8d85e458fda6bd580405f0b9
P2860
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.